# Brian Schwartz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/brian-schwartz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,442 |
| Field | Chronic Lymphocytic Leukemia Research |
| h-index | 52 |
| i10-index | 103 |
| Last Known Institution | Cyclacel Pharmaceuticals (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5045588447 |
| ORCID iD | https://orcid.org/0000-0003-2632-6351 |
| Works | 198 |

## Researcher topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Researcher university

- [Cyclacel Pharmaceuticals (United Kingdom)](https://scholariq.org/institutions/cyclacel-pharmaceuticals-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.